From exploratory pilot studies to landmark multinational clinical trials spanning 85+ countries, CRLB-GMEL delivers ISO-accredited biobanking, biomarker, proteomic and genomic services with uncompromising quality.
We are uniquely positioned to serve the complete spectrum of research — from a first feasibility study to a multi-decade global cohort — with the same expert team and ISO-accredited rigour at every scale.
Decades of experience managing specimens from 85+ countries. Our infrastructure has supported some of the most cited clinical trials in cardiovascular and population health research.
The same ISO-accredited standards, the same expert team, the same publication-quality data — available to investigator-led studies, pilot projects, and academic research collaborations of any size.
End-to-end support for the entire research lifecycle — delivering data publishable in top-tier international journals.
4,000,000+ aliquots of blood and urine in nitrogen vapour at −160°C to −180°C — the largest research biobank in Canada.
Learn More →From single-plex ELISA to high-throughput automated analysis on Roche, Siemens, Beckman Coulter, Abbott and Bio-Rad platforms.
Learn More →Olink®, SomaScan® and Alamar NULISA® — 3,000+ proteins per sample, from focused panels to proteome-wide discovery.
Learn More →Two genotyping platforms, DNA sequencing, gene expression and DNA methylation — 10 million genetic variants per DNA sample.
Learn More →Metabolomic analysis alongside genomic and proteomic data for multi-omics study designs.
Learn More →Study design, quality control, statistics and reporting — 200+ terabytes of data processed.
Learn More →Our history spans some of the most influential cardiovascular, diabetes, and population health studies ever conducted.
Whether you’re planning a global trial or a focused pilot — our team is ready to help at any scale.